Objective Epidemiologic data on falls in the population with systemic lupus erythematosus (SLE) remain sparse. We estimated ...

is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.

TitleAuthorDate Prevalence of falls in a pooled US cohort of adults with systemic lupus erythematosus: a nested cross-sectional study Laura C Plantinga, Jessica Fitzpatrick, S Sam Lim, Maria Dall’Era, ...

Objective A data-driven and expert/patient consensus-based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index ...

Objectives CD163 is a macrophage-associated scavenger receptor shed during inflammatory activation, resulting in measurable ...

Objectives To estimate the risk of venous thromboembolism (VTE) in a nationwide cohort of newly diagnosed patients with SLE ...

Objective Childhood-onset SLE (cSLE) is often described as more severe than adult-onset disease (aSLE) based largely on cross ...

Objective Belimumab has been proven to be effective for treating refractory lupus nephritis. However, the meaningful renal ...

Introduction Cognitive symptoms such as ‘brain fog’ are frequent and disabling in patients with SLE. We aimed to develop and validate the Lupus Brain Fog Severity Scale (LBFSS), the first ...

Objective SLE is a chronic autoimmune disorder with a range of symptoms. While these are broadly reported in the literature, the symptom impact of SLE on patient health-related quality of life is less ...

Objective To determine the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of subcutaneously administered mosunetuzumab, a CD20xCD3 T-cell-engaging bispecific antibody, in ...

Ocular involvement in antiphospholipid syndrome typically manifests as retinal artery or vein occlusions. Isolated progressive retinal microvascular impairment as associated with antiphospholipid ...